PhRMA Code Revisions: Benchmarking of Leading Pharmaceutical Companies' Approaches and Responses |
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| This report examines how leading
pharmaceutical and biotech companies are interpreting the new PhRMA
guidelines. The study examines the policies of 10 leading companies and
provides specific tactics and policies implemented in response to the
newly revised PhRMA Code.
The study provides a clear understanding of each company's interpretation of and response to the code in regards to the following:
* Save 5% -- Mention "PharmCast.com" when purchase. To receive more information about the study, please click on the following "Request for Info" link.
|
| [
Outsourcing Guide
] [
Cont. Education
] [
Software/Reports
] [
Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ] [ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ] [ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ] [ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ] [ Site Map ] |